Form 4: Charles River Laboratories Director Acquires Shares and Stock Options

Director Nancy C. Andrews acquired common stock and stock options in Charles River Laboratories on May 13, 2024.

Summary

• On May 13, 2024, Nancy C. Andrews, a director of Charles River Laboratories International, Inc., acquired 559 shares of common stock at a price of $228.41 per share.
• Following this transaction, Andrews directly owns 3,018 shares of common stock.
• On the same date, Andrews also acquired 1,311 stock options with an exercise price of $228.41.
• These stock options become exercisable on the earlier of May 13, 2025, or the business day prior to the company's next annual meeting of shareholders and expire on May 13, 2034.
• Andrews now beneficially owns 1,311 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed as a positive sign, but it's a routine transaction.

Positives

• A director's purchase of company stock and options can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency regarding the trading activities of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates